Oppenheimer Asset Management Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Oppenheimer Asset Management Inc.

$8.04 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$692.45 - $844.37 $15,233 - $18,576	22 Added 3.0%	756 $622,000
Q2 2023 Aug 02, 2023	BUY	$700.03 - $830.35 $10,500 - $12,455	15 Added 2.09%	734 $527,000
Q1 2023 May 10, 2023	SELL	$680.49 - $826.97 $42,190 - $51,272	-62 Reduced 7.94%	719 $590,000
Q4 2022 Feb 06, 2023	SELL	$705.89 - $766.39 $152,472 - $165,540	-216 Reduced 21.66%	781 $563,000
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $33,864 - $42,734	-59 Reduced 5.59%	997 $687,000
Q2 2022 Aug 08, 2022	BUY	$548.35 - $738.84 $53,738 - $72,406	98 Added 10.23%	1,056 $624,000
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $1.1 Million - $1.29 Million	-1,841 Reduced 65.77%	958 $669,000
Q4 2021 Feb 02, 2022	SELL	$543.48 - $670.97 $47,826 - $59,045	-88 Reduced 3.05%	2,799 $1.77 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $182,541 - $216,545	318 Added 12.38%	2,887 $1.75 Million
Q2 2021 Aug 03, 2021	BUY	$472.8 - $558.54 $104,961 - $123,995	222 Added 9.46%	2,569 $1.44 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $10.4 Million - $12.8 Million	-23,363 Reduced 90.87%	2,347 $1.11 Million
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $476,865 - $606,156	997 Added 4.03%	25,710 $12.4 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $74,086 - $89,516	136 Added 0.55%	24,713 $13.8 Million
Q2 2020 Aug 11, 2020	BUY	$493.32 - $643.92 $669,435 - $873,799	1,357 Added 5.84%	24,577 $15.3 Million
Q1 2020 May 08, 2020	BUY	$336.18 - $494.43 $7.64 Million - $11.2 Million	22,739 Added 4727.44%	23,220 $11.3 Million
Q4 2019 Feb 07, 2020	SELL	$274.13 - $376.51 $8,223 - $11,295	-30 Reduced 5.87%	481 $181,000
Q3 2019 Oct 31, 2019	SELL	$273.46 - $318.39 $1,367 - $1,591	-5 Reduced 0.97%	511 $142,000
Q2 2019 Aug 09, 2019	SELL	$299.6 - $414.82 $14,680 - $20,326	-49 Reduced 8.67%	516 $162,000
Q1 2019 Apr 24, 2019	SELL	$372.08 - $439.57 $299,896 - $354,293	-806 Reduced 58.79%	565 $233,000
Q4 2018 Jan 30, 2019	SELL	$335.82 - $403.04 $20,149 - $24,182	-60 Reduced 4.19%	1,371 $512,000
Q3 2018 Oct 26, 2018	BUY	$351.14 - $408.51 $44,945 - $52,289	128 Added 9.82%	1,431 $578,000
Q2 2018 Aug 10, 2018	BUY	$284.6 - $344.99 $62,042 - $75,207	218 Added 20.09%	1,303 $449,000
Q1 2018 May 09, 2018	SELL	$315.82 - $393.78 $3.01 Million - $3.75 Million	-9,524 Reduced 89.77%	1,085 $374,000
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $4.58 Million - $5.35 Million	10,609	10,609 $4.75 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account